These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15641629)

  • 21. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP; Lundback B; Yigla M; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
    Sher LD; Yiu G; Sakov A; Liu S; Caracta CF
    Allergy Asthma Proc; 2017 Sep; 38(5):343-353. PubMed ID: 28639542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
    J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
    Lumry WR; Conway MM; LaForce CF; Pearlman DS; Scott CA; Herje NE; Wu WW; Crim C
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.
    Katial RK; Bernstein D; Prazma CM; Lincourt WR; Stempel DA
    Allergy Asthma Proc; 2011; 32(2):127-36. PubMed ID: 21189151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
    Pearlman DS; White MV; Lieberman AK; Pepsin PJ; Kalberg C; Emmett A; Bowers B; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):227-35. PubMed ID: 11868930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroids.
    Berger WE; Ford LB; Mahr T; Nathan RA; Crim C; Edwards L; Wightman DS; Lincourt WR; Rickard K
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):393-9. PubMed ID: 12392384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone.
    Bailey W; Castro M; Matz J; White M; Dransfield M; Yancey S; Ortega H
    Curr Med Res Opin; 2008 Jun; 24(6):1669-82. PubMed ID: 18462564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate.
    Fowler SJ; Orr LC; Sims EJ; Wilson AM; Currie GP; McFarlane L; Lipworth BJ
    Chest; 2002 Aug; 122(2):618-23. PubMed ID: 12171841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma.
    Shapiro GS; Klinger NM; Ekholm BP; Colice GL
    J Asthma; 2000 Dec; 37(8):667-75. PubMed ID: 11192231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
    Calhoun WJ; Nelson HS; Nathan RA; Pepsin PJ; Kalberg C; Emmett A; Rickard KA; Dorinsky P
    Am J Respir Crit Care Med; 2001 Sep; 164(5):759-63. PubMed ID: 11549529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
    Hagiwara M; Delea TE; Stanford RH; Stempel DA
    Allergy Asthma Proc; 2010; 31(3):203-10. PubMed ID: 20534183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
    Pinnas JL; Noonan MJ; Weinstein SF; Chervinsky P; Scott CA; Herje NE; Wu W; Crim C
    J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children.
    Lyttle B; Gilles J; Panov M; Emeryk A; Wixon C
    Can Respir J; 2003 Mar; 10(2):103-9. PubMed ID: 12687029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.